Cite
Martínez-Bosch N, Cristóbal H, Iglesias M, et al. Soluble AXL is a novel blood marker for early detection of pancreatic ductal adenocarcinoma and differential diagnosis from chronic pancreatitis. EBioMedicine. 2021;75:103797doi: 10.1016/j.ebiom.2021.103797.
Martínez-Bosch, N., Cristóbal, H., Iglesias, M., Gironella, M., Barranco, L., Visa, L., Calafato, D., Jiménez-Parrado, S., Earl, J., Carrato, A., Manero-Rupérez, N., Moreno, M., Morales, A., Guerra, C., Navarro, P., & García de Frutos, P. (2021). Soluble AXL is a novel blood marker for early detection of pancreatic ductal adenocarcinoma and differential diagnosis from chronic pancreatitis. EBioMedicine, 75103797. https://doi.org/10.1016/j.ebiom.2021.103797
Martínez-Bosch, Neus, et al. "Soluble AXL is a novel blood marker for early detection of pancreatic ductal adenocarcinoma and differential diagnosis from chronic pancreatitis." EBioMedicine vol. 75 (2021): 103797. doi: https://doi.org/10.1016/j.ebiom.2021.103797
Martínez-Bosch N, Cristóbal H, Iglesias M, Gironella M, Barranco L, Visa L, Calafato D, Jiménez-Parrado S, Earl J, Carrato A, Manero-Rupérez N, Moreno M, Morales A, Guerra C, Navarro P, García de Frutos P. Soluble AXL is a novel blood marker for early detection of pancreatic ductal adenocarcinoma and differential diagnosis from chronic pancreatitis. EBioMedicine. 2021 Dec 29;75:103797. doi: 10.1016/j.ebiom.2021.103797. Epub 2021 Dec 29. PMID: 34973624; PMCID: PMC8724936.
Copy
Download .nbib
